United-Guardian, Inc. – NASDAQ:UG

United-Guardian stock price today

$7.83
-1.93
-19.86%
Financial Health
0
1
2
3
4
5
6
7
8
9

United-Guardian stock price monthly change

-10.37%
month

United-Guardian stock price quarterly change

-10.37%
quarter

United-Guardian stock price yearly change

+30.09%
year

United-Guardian key metrics

Market Cap
43.16M
Enterprise value
42.44M
P/E
12.88
EV/Sales
3.44
EV/EBITDA
10.71
Price/Sales
3.64
Price/Book
3.94
PEG ratio
4.31
EPS
0.6
Revenue
11.56M
EBITDA
3.03M
Income
2.75M
Revenue Q/Q
26.63%
Revenue Y/Y
1.69%
Profit margin
28.3%
Oper. margin
31.53%
Gross margin
53.43%
EBIT margin
31.53%
EBITDA margin
26.23%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

United-Guardian stock price history

United-Guardian stock forecast

United-Guardian financial statements

United-Guardian, Inc. (NASDAQ:UG): Profit margin
Jun 2023 2.65M 461.09K 17.4%
Sep 2023 3.05M 626.75K 20.5%
Dec 2023 2.60M 737.43K 28.29%
Mar 2024 3.25M 925.44K 28.43%
6.14%
Yield TTM
United-Guardian, Inc. (NASDAQ:UG): Payout ratio
Payout ratio 79.1%
United-Guardian, Inc. (NASDAQ:UG): Dividend Yield
2019 5.59%
2020 5.42%
2021 6.87%
2022 6.51%
2023 1.39%
United-Guardian, Inc. (NASDAQ:UG): Debt to assets
Jun 2023 11877437 1.39M 11.73%
Sep 2023 12172773 1.52M 12.5%
Dec 2023 13358552 1.96M 14.75%
Mar 2024 13047429 1.88M 14.42%
United-Guardian, Inc. (NASDAQ:UG): Cash Flow
Jun 2023 434.65K 4.84M 0
Sep 2023 1.16M -72.05K -459.38K
Dec 2023 1.12M -579 0
Mar 2024 644.12K -665.47K -1.14M

United-Guardian alternative data

United-Guardian, Inc. (NASDAQ:UG): Employee count
Aug 2023 23
Sep 2023 23
Oct 2023 23
Nov 2023 23
Dec 2023 23
Jan 2024 23
Feb 2024 23
Mar 2024 23
Apr 2024 23
May 2024 23
Jun 2024 23
Jul 2024 23

United-Guardian other data

17.06% -6.96%
of UG is owned by hedge funds
784.01K -319.86K
shares is hold by hedge funds

United-Guardian, Inc. (NASDAQ:UG): Insider trades (number of shares)
Period Buy Sel
Sep 2015 0 7600
Aug 2016 0 5926
Transaction Date Insider Security Shares Price per share Total value Source
Sale
VERNICE JOSEPH J officer: Vice President
Common Stock 1,400 N/A N/A
Sale
VERNICE JOSEPH J officer: Vice President
Common Stock 4,526 N/A N/A
Sale
PARKER BETSEE 10 percent owner
Common Stock par $.10 7,600 N/A N/A
Sale
PARKER BETSEE 10 percent owner
Common Stock par $.10 4,485 N/A N/A
Sale
PARKER BETSEE 10 percent owner
Common Stock par $.10 21,252 N/A N/A
Sale
PARKER BETSEE 10 percent owner
Common Stock Par $.10 2,664 N/A N/A
Sale
PARKER BETSEE 10 percent owner
Common Stock par $.10 263 N/A N/A
Sale
PARKER BETSEE 10 percent owner
Common Stock par $.10 3,522 N/A N/A
Sale
PARKER BETSEE 10 percent owner
Common Stock par $.10 3,448 N/A N/A
Sale
PARKER BETSEE 10 percent owner
Common Stock par $.10 9,630 N/A N/A
Insider Compensation
Mr. Kenneth H. Globus (1952) Pres, Gen. Counsel, Chief Executive Officer, Principal Executive Officer & Chairman $440,750
Mr. Peter A. Hiltunen (1959) Senior Vice President & Production Mang. $217,710
Ms. Andrea J. Young (1969) Chief Financial Officer, Treasurer, Controller, Sec. & HR Mang.
$148,570
Tuesday, 12 November 2024
zacks.com
Friday, 8 November 2024
globenewswire.com
Wednesday, 23 October 2024
wsj.com
Thursday, 26 September 2024
proactiveinvestors.co.uk
Tuesday, 24 September 2024
kitco.com
Tuesday, 13 August 2024
zacks.com
Friday, 9 August 2024
globenewswire.com
Friday, 2 August 2024
benzinga.com
Friday, 12 July 2024
globenewswire.com
Thursday, 11 July 2024
benzinga.com
zacks.com
Thursday, 20 June 2024
benzinga.com
Tuesday, 11 June 2024
watchdoguganda.com
Friday, 10 May 2024
globenewswire.com
Tuesday, 16 April 2024
Benzinga
Sunday, 14 April 2024
Reuters
Friday, 12 January 2024
FXEmpire
Tuesday, 9 January 2024
FXEmpire
Tuesday, 19 September 2023
Benzinga
Wednesday, 30 August 2023
Benzinga
Monday, 21 August 2023
Market Watch
Friday, 7 July 2023
Seeking Alpha
Monday, 20 March 2023
Yahoo Finance
Tuesday, 28 February 2023
CNBC
Thursday, 19 January 2023
Seeking Alpha
Tuesday, 13 December 2022
CNBC
Thursday, 25 August 2022
Market Watch
Tuesday, 19 July 2022
Market Watch
Wednesday, 29 June 2022
Market Watch
Tuesday, 26 April 2022
Kitco
  • What's the price of United-Guardian stock today?

    One share of United-Guardian stock can currently be purchased for approximately $7.83.

  • When is United-Guardian's next earnings date?

    Unfortunately, United-Guardian's (UG) next earnings date is currently unknown.

  • Does United-Guardian pay dividends?

    Yes, United-Guardian pays dividends and its trailing 12-month yield is 6.14% with 79% payout ratio. The last United-Guardian stock dividend of $0.65 was paid on 7 Dec 2021.

  • How much money does United-Guardian make?

    United-Guardian has a market capitalization of 43.16M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 14.28% to 10.89M US dollars.

  • What is United-Guardian's stock symbol?

    United-Guardian, Inc. is traded on the NASDAQ under the ticker symbol "UG".

  • What is United-Guardian's primary industry?

    Company operates in the Consumer Defensive sector and Household & Personal Products industry.

  • How do i buy shares of United-Guardian?

    Shares of United-Guardian can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are United-Guardian's key executives?

    United-Guardian's management team includes the following people:

    • Mr. Kenneth H. Globus Pres, Gen. Counsel, Chief Executive Officer, Principal Executive Officer & Chairman(age: 73, pay: $440,750)
    • Mr. Peter A. Hiltunen Senior Vice President & Production Mang.(age: 66, pay: $217,710)
    • Ms. Andrea J. Young Chief Financial Officer, Treasurer, Controller, Sec. & HR Mang.(age: 56, pay: $148,570)
  • How many employees does United-Guardian have?

    As Jul 2024, United-Guardian employs 23 workers.

  • When United-Guardian went public?

    United-Guardian, Inc. is publicly traded company for more then 45 years since IPO on 17 Mar 1980.

  • What is United-Guardian's official website?

    The official website for United-Guardian is u-g.com.

  • Where are United-Guardian's headquarters?

    United-Guardian is headquartered at 230 Marcus Boulevard, Hauppauge, NY.

  • How can i contact United-Guardian?

    United-Guardian's mailing address is 230 Marcus Boulevard, Hauppauge, NY and company can be reached via phone at +63 12730900.

United-Guardian company profile:

United-Guardian, Inc.

u-g.com
Exchange:

NASDAQ

Full time employees:

23

Industry:

Household & Personal Products

Sector:

Consumer Defensive

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.

230 Marcus Boulevard
Hauppauge, NY 11788

CIK: 0000101295
ISIN: US9105711082
CUSIP: 910571108